Fact CheckerSign in

NCT06978894Recruiting

Predicting Psychotic Relapse Using Speech-Based Early Detection

Source: ClinicalTrials.gov · Last updated 18 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Psychotic disorders, including schizophrenia and affective psychosis, are severe mental health conditions marked by recurrent episodes that contribute to long-term disability. Relapses, characterized by the re-emergence of psychotic symptoms after remission, are a critical factor in the progression of these disorders, increasing risks such as suicide, cognitive impairment, and unemployment. This study aims to develop a novel, speech-based digital model to predict relapses in individuals with psychosis. Building on previous research into language abnormalities in schizophrenia, the study will employ a longitudinal design across Early Psychosis Intervention (EPI) clinics in Ontario and Quebec to advance relapse prediction

Status (registry)
Recruiting
Study type
Observational
Enrollment
250 (estimated)
First submitted
13 Jan 2025
Start date
27 May 2024
Primary completion date
1 Jul 2028
Lead sponsor
Douglas Mental Health University Institute
NCT number
NCT06978894

What you commit to

  • Study type: Observational
  • Planned participants: 250
  • From 27 May 2024 to the primary completion date, 1 Jul 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe comorbid speech or language disorders (e.g., aphasia)
  • Primary diagnosis of non-psychotic disorders

Other

  • Inability to provide consent or complete assessments

Who the study is looking for

  • Age must be 16 years and older
  • Diagnosis must meet DSM-5 criteria for psychotic disorders, including schizophrenia, schizoaffective disorder, or related conditions
  • Fluency in English or French
  • Must be currently receiving treatment through an EPI program

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Robarts Research Institute
Coordinator of this site? Confirm its status
LondonCanadaRecruiting
Douglas Mental Health University Institute
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting
Vitam
Coordinator of this site? Confirm its status
QuébecCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.